| Identification | Back Directory | [Name]
1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) | [CAS]
194920-55-3 | [Synonyms]
1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) | [Molecular Formula]
C26H44N6O6S2 | [MOL File]
194920-55-3.mol | [Molecular Weight]
600.79 |
| Chemical Properties | Back Directory | [Boiling point ]
1004.0±65.0 °C(Predicted) | [density ]
1.222±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
13.60±0.40(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
Biotin-PEG-Biotin is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | [References]
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562. DOI:10.1016/j.ebiom.2018.09.005 |
|
|